Published in Cancer Weekly, February 8th, 2005
The report suggests that more intensive lab tests like liver scans and molecular tumor markers do not improve the chances of detecting a recurrence of cancer or increase survival rates among former breast cancer patients.
The finding is at odds with the usual treatment for breast cancer patients, according to Roldano Fossati of the Mario Negri Institute in Italy and colleagues (Rojas et al. Follow-up strategies for women treated for early breast...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.